IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,582,000 | -70.9% | 18,606 | -87.9% | 0.01% | -70.6% |
| Q2 2020 | $5,428,000 | +689.0% | 153,137 | +199.2% | 0.02% | +466.7% |
| Q1 2020 | $688,000 | -30.4% | 51,178 | +9.8% | 0.00% | 0.0% |
| Q4 2019 | $988,000 | -7.1% | 46,594 | -42.0% | 0.00% | 0.0% |
| Q3 2019 | $1,063,000 | -1.6% | 80,319 | +3.0% | 0.00% | -25.0% |
| Q2 2019 | $1,080,000 | -24.1% | 77,980 | +5.1% | 0.00% | -20.0% |
| Q1 2019 | $1,422,000 | +712.6% | 74,162 | +778.7% | 0.01% | +400.0% |
| Q4 2018 | $175,000 | -13.4% | 8,440 | -11.8% | 0.00% | 0.0% |
| Q3 2018 | $202,000 | -84.9% | 9,574 | -83.1% | 0.00% | -80.0% |
| Q2 2018 | $1,339,000 | +1992.2% | 56,551 | +1191.4% | 0.01% | – |
| Q1 2018 | $64,000 | +42.2% | 4,379 | +57.0% | 0.00% | – |
| Q4 2017 | $45,000 | -2.2% | 2,790 | -15.9% | 0.00% | – |
| Q3 2017 | $46,000 | +253.8% | 3,318 | +128.7% | 0.00% | – |
| Q2 2017 | $13,000 | +160.0% | 1,451 | +73.8% | 0.00% | – |
| Q1 2017 | $5,000 | – | 835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |